Prof. James OโDonnell is a leading academic at RCSI University of Medicine and Health Sciences. His expertise, research group and leadership in translational clinical science support the development of new biomarkers and therapies.
Von Willebrand Disease Therapeutics
New therapeutics regulating von Willebrand disease related excessive bleeding


